Immunotherapy

Taming food-induced immune disorders

The US continues to lead in oncology approvals

Genmab looks ahead to next phase of growth

Long-term strategies for immuno-oncology

Novel immunotherapy arises from collaboration

Medigene on a new course

Using the accelerator and brake to treat cancer

How Pharma is targeting checkpoint inhibitors

Immunotherapies start to transform cancer care

Bringing exhausted T cells back from the brink